Wright Medical can submit more data to FDA for Augment bone graft
Wright Medical says it struck a deal with the FDA to submit more data on its Augment bone graft, previously deemed unapprovable by the watchdog agency.
Wright Medical (NSDQ:WMGI) said the FDA agreed to let it submit additional data for its pre-market approval application for the Augment bone graft it bought along with BioMimetic Therapeutics in 2012.
Wright Medical Group Inc., Food & Drug Administration (FDA)News Well, Pre-Market Approval (PMA), Regulatory/Compliance, Resorbable bone materialsread more
Source: Mass Device - Category: Medical Equipment Authors: Brad Perriello Source Type: news
More News: Bone Graft | Medical Devices